05 April 2019
Visiongain has published a new pharma report Top 25 Translational Regenerative Medicine Manufacturers 2019: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation, Other Companies.
In 2018, the global translational regenerative medicine is estimated at $28bn. The global translational regenerative medicine market is highly competitive and fragmented with the presence of several vendors. The competition is likely to increase with advances in R&D and technological innovations. The market is characterized by the presence of well-diversified international and local vendors that provide cost-effective products with limited features and functionalities.
This report profiled the selected companies: Medtronic, Acelity, Integra Lifesciences, NuVasive, Orthofix International, Anika Therapeutics, Organogenesis, UniQure, TiGenix, Vericel Corporation and other companies.
The lead analyst commented that "Advancements in biological sciences have shown a positive influence on the regenerative medicine market. There are new technological advancements in terms of drug manufacturing, development, and delivery. Many cell therapy products based on mesenchymal stem cells are available in the market because of their self-renewal ability and their presence in almost all tissues. The discovery of novel scaffolds and various growth and control factors have shown promising results in stimulating tissue formation. This has led to a shift in the focus to regenerative therapies over conventional methods of treatment."
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 207 336 6100.
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Ageing population will be more susceptible to such diseases and is one of the key factors driving the growth of the global biological drugs market. In most of the developed world, the share of elderly population is almost touching a quarter of the population.
26 January 2022
Some of the factors driving the market growth are the increasing prevalence of skin and eye diseases, high incidences of burn incidences and the growing prevalence of diabetes.
26 January 2022
The growing adoption advanced e-clinical solutions, rising focus on clinical research, increasing investment in R&D, and adoption of decentralized clinical trials by biopharmaceutical companies are some of the major factors that drive the growth of the global decentralized clinical trials market.
24 January 2022
The nasal drug delivery market will expand rapidly due to rising patient preference for nasal medication delivery due to ease of administration and efficacy, increased self-administration practises, and increased demand for home healthcare equipment.